ClearPoint Neuro (CLPT) Shares Outstanding (2011 - 2026)

ClearPoint Neuro has reported Shares Outstanding (Entity) for 16 years, with the latest figure at $30.0 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 7.17% year-over-year to $30.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.0 million (up 7.17% YoY) and the FY2025 annual result came in at $29.4 million, up 6.34% from the prior year.
• Shares Outstanding (Entity) advanced to $30.0 million in Q1 2026 per CLPT's latest filing, from $29.4 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $30.0 million in Q1 2026 and troughed at $23.7 million in Q1 2022.
• A 5-year average of $26.5 million and a median of $27.4 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) advanced 14.65% in 2022, then gained 0.3% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $24.6 million in 2022, then gained by 0.3% to $24.7 million in 2023, then increased by 12.03% to $27.6 million in 2024, then rose by 6.34% to $29.4 million in 2025, then rose by 2.1% to $30.0 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $30.0 million, $29.4 million, and $28.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.